| Literature DB >> 35317149 |
Yu-Jia Zhang1, Rong-Chao Xiang1, Jun Li1, Yong Liu1, Si-Ming Xie1, Liang An1, Hua-Lin Li1, Gang Mai2.
Abstract
BACKGROUND: D2 lymph node dissection for advanced gastric cancer is advocated, and station 8p lymph node should be considered in selected patients, which is, however, technically difficult. AIM: To introduce a new and easy-to-perform procedure for dissection of the lymph nodes superior to the pancreas.Entities:
Keywords: Laparoscopic radical gastrectomy; Lymph node; Lymph node metastasis; Lymphadenectomy; Portal vein priority
Year: 2022 PMID: 35317149 PMCID: PMC8891763 DOI: 10.12998/wjcc.v10.i6.1834
Source DB: PubMed Journal: World J Clin Cases ISSN: 2307-8960 Impact factor: 1.337
Figure 1The position of the patients, the operators and distribution of the trocars during laparoscopic radical gastrectomy.
Figure 2The boundary of the portal triangle. PV: Portal vein; CHA: Common hepatic artery; GDA: Gastroduodenal artery; DPA: Dorsal pancreatic artery; PHA: Proper hepatic artery; SPA: Spleen artery; SPV: Spleen vein; IVC: Inferior vena cava.
Figure 3Portal triangle dissection. PV: Portal vein; CHA: Common hepatic artery; GDA: Gastroduodenal artery; PHA: Proper hepatic artery; SPA: Spleen artery.
Baseline characteristics and surgical factors
|
|
|
| Sex (%) | |
| Male | 34 (66.7) |
| Female | 17 (33.3) |
| Age (%) | |
| < 65 yr | 28 (54.9) |
| ≥ 65 yr | 23 (45.1) |
| BMI (%) | |
| < 24 | 34 (66.7) |
| 24-27 | 11 (21.6) |
| > 27 | 4 (7.8) |
| TNM staging (%) | |
| I | 4 (7.8) |
| II | 13 (25.5) |
| III | 33 (64.7) |
| IV | 1 (2.0) |
| Duration of LND in the upper pancreas (min) | 67.7 ± 6.9 |
| Intraoperative blood loss (mL) | 78.8 ± 17.8 |
| Postoperative exhaust time (d) | 3.1 ± 0.9 |
| Postoperative complications (%) | 4 (7.8) |
BMI: Body mass index; T: Primary tumor; N: Regional lymph nodes; M: Distant metastasis; LND: Lymphadenectomy.
Nodal status after superior pancreatic lymphadenectomy with portal vein priority via posterior common hepatic artery approach
|
|
|
|
|
|
|
| 5 | 12 | 23.5 | 55 | 12 | 21.8 |
| 7 | 8 | 15.7 | 164 | 19 | 11.6 |
| 8a | 9 | 17.7 | 122 | 16 | 13.1 |
| 8p | 5 | 9.8 | 14 | 2 | 14.3 |
| 9 | 7 | 13.7 | 127 | 10 | 7.9 |
| 11p | 4 | 7.8 | 54 | 3 | 5.6 |
| 12a | 4 | 7.8 | 44 | 3 | 6.8 |
| 12p | 2 | 3.9 | 24 | 1 | 4.2 |
LNM: Lymph node metastasis; TNLE: Total number of lymph node examined; LN: Lymph node.